FDA Warns Off-Label Prescription of Painkiller Fentora Can Cause Death and Life-Threatening Side Effects By SEO Admin on September 27, 2007

The Food and Drug Administration issued a warning today about the risk of potentially fatal overdoses with Fentora, a narcotic painkiller manufactured by Cephalon. The action comes less than two weeks after the company sent a letter to doctors notifying them of three drug-related deaths. The FDA has received reports of death and life-threatening side effects in patients who have taken Fentora. The reported deaths were the result of improper selection of patients, dosing, or improper product substitution, according to the FDA. One of the deaths was a suicide. Last October, the FDA approved Fentora for use in cancer patients who experience intense bursts of pain. However, the drug is also sometimes prescribed to treat migraines and short-term pain in non-cancer patients. According to the government warning, using Fentora for off-label, or non-approved, purposes could lead to deadly overdose, particularly in patients who are not taking narcotic painkillers on a regular basis. All three reported deaths were in patients taking Fentora for off-label uses. Two of the patients were taking the drug to treat migraine headaches. Fentora is a strong narcotic painkiller that should only be used for treating breakthrough pain in cancer patients who are opioid-tolerant, meaning they take narcotic pain medicines around the clock. Opioid medicines include morphine (Kadian, MS Contin, Oramorph, and others), oxycodone (Oxycontin), and hydromorphone (Dilaudid). The FDA stresses the following safety information for Fentora: Fentora should not be used to treat any type of short-term pain including headaches, migraines, postoperative pain, or pain due to injury. Fentora should not be used by patients who only take narcotic pain medications occasionally. Health care professionals must not directly substitute Fentora for other fentanyl medicines, including Actiq. Doctors must select the Fentora dose carefully for each patient. Patients taking Fentora and their caregivers must understand how to use Fentora safely and follow the directions in the drug's Medication Guide exactly. Health care professionals who prescribe Fentora and patients who use Fentora (and their caregivers) should be aware of the signs of fentanyl overdose. Signs of fentanyl overdose include trouble breathing or shallow breathing; tiredness, extreme sleepiness, or sedation; inability to think, talk, or walk normally; and feeling faint, dizzy, or confused. If these signs occur, patients or their caregivers should get medical attention right away. Fentora and its predecessor, Actiq, are approved by the Food and Drug Administration only for use in cancer patients, but they are often prescribed by physicians "off-label" for such ailments as headaches and back pain. Fentora and Actiq contain fentanyl, a highly addictive substance 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as cocaine and methamphetamine. Schedule II drugs have the highest potential for abuse and an associated risk of fatal overdose. Actiq has been associated with more than 120 deaths. Cephalon, the maker of both Fentora and Actiq, has been accused of marketing its drugs for uses not approved by the FDA and is currently the target of state and federal investigations. The company has denied the allegations. The personal injury lawyers at Levine & Slavit have decades of experience handling personal injury claims including those involving dangerous and defective products . For 50 years spanning 3 generations, we have obtained results for satisfied clients. If you or someone close to you has been injured or killed by a product that was not properly manufactured, designed or labeled, contact the personal injury lawyers at Levine & Slavit for their help. We have offices in Manhattan and Long Island, handling cases in New York City, the Bronx, Brooklyn, Queens and surrounding areas.

Related to This

Levine & Slavit, PLLC Logo

Levine & Slavit, PLLC

The law firm of Levine & Slavit, PLLC has served clients in Long Island and the Greater New York City-area since 1957. We are a team of personal injury and wrongful death lawyers who work tirelessly for victims' rights. Our team is licensed and affiliated with the:

  • New York State Bar Association
  • New Jersey Board of Bar Examiners
  • Florida Board of Bar Examiners
  • U.S. District Court Eastern District of New York
  • U.S. District Court Southern District of New York

Please contact our practice online for a free consultation or call (212) 687-2777 to speak to an attorney today. 

Contact Us Today

Rate, Review & Explore

Social Accounts Sprite
Google map image of our location in 60 E 42nd St Ste 2101 New York, NY

Manhattan Office

60 E 42nd St
Ste 2101
New York, NY 10165

Open Today 9:00am - 5:00pm

By Appointment Only

Google map image of our location in 350 Willis Ave Ste 100 Long Island, NY

Mineola Office

350 Willis Ave
Ste 100
Long Island, NY 11501

Open Today 9:00am - 5:00pm

By Appointment Only

(212) 687-2777 Send a message